OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Pathogenesis and novel therapeutics of regulatory T cell subsets and interleukin-2 therapy in systemic lupus erythematosus
Yi‐Giien Tsai, P. F. Liao, Kai‐Hung Hsiao, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 13
Yi‐Giien Tsai, P. F. Liao, Kai‐Hung Hsiao, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 13
Showing 13 citing articles:
Immunotherapy Strategy for Systemic Autoimmune Diseases: Betting on CAR-T Cells and Antibodies
Vitaly Chasov, Ekaterina Zmievskaya, Irina Ganeeva, et al.
Antibodies (2024) Vol. 13, Iss. 1, pp. 10-10
Open Access | Times Cited: 18
Vitaly Chasov, Ekaterina Zmievskaya, Irina Ganeeva, et al.
Antibodies (2024) Vol. 13, Iss. 1, pp. 10-10
Open Access | Times Cited: 18
Clinical and laboratory characteristics of early-onset and delayed-onset lupus nephritis patients: A single-center retrospective study
Joanna Kosałka-Węgiel, Radosław Dziedzic, Andżelika Siwiec-Koźlik, et al.
Rheumatology International (2024) Vol. 44, Iss. 7, pp. 1283-1294
Open Access | Times Cited: 10
Joanna Kosałka-Węgiel, Radosław Dziedzic, Andżelika Siwiec-Koźlik, et al.
Rheumatology International (2024) Vol. 44, Iss. 7, pp. 1283-1294
Open Access | Times Cited: 10
Regulatory T Cells and Their Derived Cell Pharmaceuticals as Emerging Therapeutics Against Autoimmune Diseases
Yu Liu, Yiqiu Fu, Rourou Miao, et al.
Advanced Functional Materials (2024)
Closed Access | Times Cited: 5
Yu Liu, Yiqiu Fu, Rourou Miao, et al.
Advanced Functional Materials (2024)
Closed Access | Times Cited: 5
Upregulated TCF1 + Treg Cells With Stronger Function in Systemic Lupus Erythematosus Through Activation of the Wnt‐β‐Catenin
Xingyue Zeng, Yiming Gao, Ayibaota Bahabayi, et al.
Immunology (2025)
Closed Access
Xingyue Zeng, Yiming Gao, Ayibaota Bahabayi, et al.
Immunology (2025)
Closed Access
Revisiting Migraine Pathophysiology: from Neurons To Immune Cells Through Lens of Immune Regulatory Pathways
Sugumar Subalakshmi, Rapuru Rushendran, Chitra Vellapandian
Journal of Neuroimmune Pharmacology (2025) Vol. 20, Iss. 1
Closed Access
Sugumar Subalakshmi, Rapuru Rushendran, Chitra Vellapandian
Journal of Neuroimmune Pharmacology (2025) Vol. 20, Iss. 1
Closed Access
Identification of cellular senescence-related genes as biomarkers for lupus nephritis based on bioinformatics
Wei Chen, Xiaofang Wang, Guoshun Huang, et al.
Frontiers in Genetics (2025) Vol. 16
Open Access
Wei Chen, Xiaofang Wang, Guoshun Huang, et al.
Frontiers in Genetics (2025) Vol. 16
Open Access
Systemic lupus erythematosus therapeutic strategy: From immunotherapy to gut microbiota modulation
Vitaly Chasov, Ekaterina Zmievskaya, Irina Ganeeva, et al.
Journal of Biomedical Research (2024) Vol. 38, Iss. 6, pp. 531-531
Open Access | Times Cited: 3
Vitaly Chasov, Ekaterina Zmievskaya, Irina Ganeeva, et al.
Journal of Biomedical Research (2024) Vol. 38, Iss. 6, pp. 531-531
Open Access | Times Cited: 3
Epigenetic regulation of immune cells in systemic lupus erythematosus: insight from chromatin accessibility
Zhao‐Xing Gao, He Tian, Peng Zhang, et al.
Expert Opinion on Therapeutic Targets (2024) Vol. 28, Iss. 7, pp. 637-649
Closed Access | Times Cited: 2
Zhao‐Xing Gao, He Tian, Peng Zhang, et al.
Expert Opinion on Therapeutic Targets (2024) Vol. 28, Iss. 7, pp. 637-649
Closed Access | Times Cited: 2
Deciphering Regulatory T-Cell Dynamics in Cancer Immunotherapy: Mechanisms, Implications, and Therapeutic Innovations
Sankha Bhattacharya, Gaurav Paraskar, Megha Jha, et al.
ACS Pharmacology & Translational Science (2024) Vol. 7, Iss. 8, pp. 2215-2236
Closed Access | Times Cited: 2
Sankha Bhattacharya, Gaurav Paraskar, Megha Jha, et al.
ACS Pharmacology & Translational Science (2024) Vol. 7, Iss. 8, pp. 2215-2236
Closed Access | Times Cited: 2
Progress of rituximab in the treatment of systemic lupus erythematosus and lupus nephritis
Shouqi Mo, Yilan Li, Junbing He, et al.
Frontiers in Medicine (2024) Vol. 11
Open Access | Times Cited: 2
Shouqi Mo, Yilan Li, Junbing He, et al.
Frontiers in Medicine (2024) Vol. 11
Open Access | Times Cited: 2
Epigenetic regulation of FOXP3 gene expression in relation to impaired function of regulatory T cells in systemic lupus erythematosus
Parnian Fakour, Ata Shirizadeh, Ahmad Tahamoli‐Roudsari, et al.
Exploration of Immunology (2024), pp. 640-657
Open Access | Times Cited: 1
Parnian Fakour, Ata Shirizadeh, Ahmad Tahamoli‐Roudsari, et al.
Exploration of Immunology (2024), pp. 640-657
Open Access | Times Cited: 1
From promise to practice: CAR T and Treg cell therapies in autoimmunity and other immune-mediated diseases
Yannick Bulliard, Robert A. Freeborn, Molly Javier Uyeda, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Yannick Bulliard, Robert A. Freeborn, Molly Javier Uyeda, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Interferon signature in the development of SLE: molecular mechanisms, approaches to diagnosis and treatment
TO Nakonechnaya, Irina A. Shagina, M.Y. Myshkin, et al.
Bulletin of Russian State Medical University (2024), Iss. 2024(3)
Open Access
TO Nakonechnaya, Irina A. Shagina, M.Y. Myshkin, et al.
Bulletin of Russian State Medical University (2024), Iss. 2024(3)
Open Access
